Gabriel Antherieu

4PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 10, 2026
Intensified Rituximab, Methotrexate, Procarbazine, and Cytarabine (R-MPVA) Regimen With Sequential Addition of Etoposide to R-MPV and Ifosfamide to R-AraC for Newly Diagnosed Primary CNS Lymphoma Patients Aged Between 60 and 70 Years: An LOC Network Study.

|Dec 02, 2025
Neutropenic events associated with new anticancer treatments, from pathophysiology to practice: a scoping review-NEW Group (Neutropenic Events Working Group).

Gabriel Antherieu, Vincent Thibaud, Pierre Sesques

|Apr 20, 2023
Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PARPi)-Induced Lymphopenia: A Scoping Review of the Literature and Internal Analysis of a Retrospective Database.

Gabriel Antherieu, Maël Heiblig, Gilles Freyer

|Feb 14, 2023
Chronic myelomonocytic leukemia transdifferentiation landscape: From histiocytosis to blastic plasmacytoid dendritic cell neoplasm.

Gabriel Antherieu, Marie Donzel, Brigitte Balme

Pageof 1

Frequent Collaborators

1 joint publications

Marie Donzel

1 joint publications

Philippe Rey

1 joint publications

Thiébaud Picart

1 joint publications

Lucie Obéric